(Q39262117)

10 September 2017

Involvement of Ext1 and heparanase in migration of mouse FBJ osteosarcoma cells (English)

1 reference

10 September 2017

Yinan Wang

1

1 reference

10 September 2017

XiaoYan Yang

2

1 reference

10 September 2017

Sadako Yamagata

3

1 reference

10 September 2017

Tatsuya Yamagata

4

1 reference

10 September 2017

Toshinori Sato

5

1 reference

10 September 2017

language of work or name

1 reference

10 October 2012

1 reference

Molecular and Cellular Biochemistry

10 September 2017

1 reference

10 September 2017

373

1 reference

10 September 2017

63-72

1 reference

10 September 2017

1-2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-012-1475-8

10 September 2017

0 references

cites work

Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Heparan sulfate proteoglycans in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Natural history study of hereditary multiple exostoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Substrate specificity of heparanases from human hepatoma and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Unraveling the specificity of heparanase utilizing synthetic substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Glycan changes: cancer metastasis and anti-cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Structural analysis of glycosphingolipid analogues obtained by the saccharide primer method using CE-ESI-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Azido glycoside primer: a versatile building block for the biocombinatorial synthesis of glycosphingolipid analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Glycosylation of dodecyl 2-acetamido-2-deoxy-beta-D-glucopyranoside and dodecyl beta-D-galactopyranosyl-(1-->4)-2-acetamido-2-deoxy-beta-D-glucopyranoside as saccharide primers in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Glycosylation of Nα-lauryl-O-(β-D-xylopyranosyl)-L-serinamide as a saccharide primer in cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

FBJ virus-induced osteosarcoma has type V collagen consisting of A, B and C-like chains in addition to type I collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Ganglioside GD1a inhibits HGF-induced motility and scattering of cancer cells through suppression of tyrosine phosphorylation of c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Ganglioside GD1a negatively regulates hepatocyte growth factor expression through caveolin-1 at the transcriptional level in murine osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Ganglioside GD1a regulation of caveolin-1 and Stim1 expression in mouse FBJ cells: augmented expression of caveolin-1 and Stim1 in cells with increased GD1a content

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization: chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Novel heparan sulfate structures revealed by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Roles of heparan-sulphate glycosaminoglycans in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Gene expression pattern in canine mammary osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Induction of heparanase-1 expression by mutant B-Raf kinase: role of GA binding protein in heparanase-1 promoter activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Tumor suppressor p53 regulates heparanase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1475-8

Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses

21 January 2018

1 reference

12 December 2020

Synthesis and sorting of proteoglycans

1 reference

12 December 2020

Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer

1 reference

12 December 2020

Gelatinases of murine metastatic tumor cells

1 reference

12 December 2020

Inhibition of highly metastatic FBJ-LL cell migration by ganglioside GD1a highly expressed in poorly metastatic FBJ-S1 cells

1 reference

12 December 2020

Suppression by ganglioside GD1A of migration capability, adhesion to vitronectin and metastatic potential of highly metastatic FBJ-LL cells

1 reference

12 December 2020

Glycosylation of amphipathic lactoside primers with consequent inhibition of endogenous glycosphingolipid synthesis

1 reference

12 December 2020

Glycosylation of lactosylceramide analogs in animal cells: amphipathic disaccharide primers for glycosphingolipid synthesis

1 reference

12 December 2020

Accelerated biosynthesis of neolacto-series glycosphingolipids in differentiated mouse embryonal carcinoma F9 cells detected by using dodecyl N-acetylglucosaminide as a saccharide primer

1 reference

12 December 2020

10.1007/S11010-012-1475-8

Identifiers

DOI

1 reference

10 September 2017

1 reference